[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371604-105":59,"doc-detail-371604-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tumor-promoting-function-of-paternally-expressed-gene-10-and-its-immunogenicity-in-inducing-anti-tumor-helper-t-cells-in-head-and-neck-squamous-cell-carcinoma","Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinoma","","Paternally expressed gene 10 (PEG10), primarily expressed in the placenta, shows extremely low or absent levels in normal tissues yet is up-regulated in multiple cancers, making it a candidate target for cancer immunotherapy. Its expression and function in head and neck squamous cell carcinoma (HNSCC), as well as the immunogenicity of PEG10-derived T-cell epitopes, were investigated. PEG10 is expressed in HNSCC and high expression correlates with poor survival. PEG10 knockdown reduces HNSCC proliferation, migration, and invasion and reshapes gene expression programs. A PEG10-derived peptide epitope (PEG10216-232) elicits antigen-specific and promiscuous HLA-DR-restricted helper T lymphocyte responses, with PEG10-specific HTLs showing direct cytotoxicity against PEG10-positive HNSCC cells in an HLA-DR-restricted manner, and precursor T cells reactive to PEG10216-232 detected in patients. These findings support PEG10 as an immunotherapeutic target for HNSCC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-promoting-function-of-paternally-expressed-gene-10-and-its-immunogenicity-in-inducing-anti-tumor-helper-t-cells-in-head-and-neck-squamous-cell-carcinoma/371604/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-promoting-function-of-paternally-expressed-gene-10-and-its-immunogenicity-in-inducing-anti-tumor-helper-t-cells-in-head-and-neck-squamous-cell-carcinoma/371604.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is PEG10 and why is it considered a potential cancer immunotherapy target?","Question",{"text":112,"@type":113},"PEG10 is primarily expressed in the placenta, with extremely low or absent expression in normal tissues, but it is up-regulated in various cancers, suggesting it can serve as an immunotherapy target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does PEG10 expression relate to patient outcomes in head and neck squamous cell carcinoma?",{"text":117,"@type":113},"High PEG10 expression in HNSCC is associated with poor patient survival.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study identify as a PEG10-derived helper T-cell epitope and how does it work?",{"text":121,"@type":113},"The study identified a PEG10-derived peptide epitope (PEG10216-232) that induces antigen-specific and promiscuous HLA-DR-restricted helper T lymphocyte responses. PEG10-specific HTLs can directly kill PEG10-positive HNSCC cells in an HLA-DR-restricted manner.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371604,1790231851,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Cancer Immunology, Immunotherapy (2025) 74:251 [https://doi.org/10.1007/s00262-025-041](https://doi.org/10.1007/s00262-025-041)10-3  \nTumor‑promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti‑tumor helper T cells in head and neck squamous cell carcinoma  \nHiroki Komatsuda1,2 · Toshihiro Nagato1 · Akemi Kosaka1 · Takayuki Ohkuri1 · Takaaki Sasaki3 · Takumi Kumai2,4 · Michihisa Kono2 · Hidekiyo Yamaki2 · Risa Wakisaka2 · Shunsuke Yasuda1,5 · Takahiro Inoue1,2 · Ryusuke Hayashi2 · Nanami Ujiie1,5 · Ryosuke Sato2 · Kenzo Ohara2,4 · Kan Kishibe2 · Tatsuya Hayashi2 · Miki Takahara2 ·  \nHiroya Kobayashi1  \nReceived: 18 March 2025 / Accepted: 4 June 2025 / Published online: 25 June 2025 © The Author(s) 2025  \nAbstract  \nPaternally expressed gene 10 (PEG10) is expressed primarily in the placenta; its expression is extremely low or absent in normal tissues but up-regulated in various cancers, indicating that PEG10 is a potential target for cancer immunotherapy. However, the expression and role of PEG10 in head and neck squamous cell carcinoma (HNSCC) and the immunogenicity of possible PEG10-derived T-cell epitopes remain unclear. In the present study, we show that PEG10 is expressed in HNSCC, and its high expression is associated with poor patient survival. Suppression of PEG10 expression attenuated the proliferation, migration, and invasion of HNSCC cells and altered their gene expression profiles. We also identified a PEG10-derived peptide epitope (PEG10216-232) capable of eliciting antigen-specific and promiscuous human leukocyte antigen (HLA)-DR– restricted helper T lymphocyte (HTL) responses. Notably, PEG10-specific HTLs exerted direct cytotoxicity against PEG10-positive HNSCC cells in an HLA-DR–restricted manner. Moreover, precursor T cells that react to PEG10216-232 peptide were detected in HNSCC patients. These results indicate that PEG10 plays an important role in HNSCC tumorigenesis and qualifies as an immunotherapeutic target against HNSCC. The helper epitope peptide of PEG10 could effectively stimulate antigen-specific HTLs and induce anti-tumor responses against PEG10-positive cancers, including HNSCC.  \nKeywords Paternally expressed gene 10 · Head and neck squamous cell carcinoma · Helper T lymphocytes · Epitope · Peptide vaccine · Placenta  \n* Toshihiro Nagato[rijun@asahikawa-med.ac.jp](rijun@asahikawa-med.ac.jp)  \n* Hiroya Kobayashi [hiroya@asahikawa-med.ac.jp](hiroya@asahikawa-med.ac.jp)  \n1 Department of Pathology, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa 078-8510, Japan  \n2 Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan  \n3 Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan  \n4 Department of Innovative Head and Neck Cancer Research and Treatment, Asahikawa Medical University, Asahikawa, Japan  \n5 Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Asahikawa, Japan  \nAbbreviations  \nAb Antibody  \nAPC Antigen-presenting cell  \nATCC American Type Culture Collection  \nBP Biological process  \nCCK-8 Cell Counting Kit-8  \nCPA Cancer-placental antigen  \nCTA Cancer-testis antigen  \nCTL Cytotoxic T lymphocyte  \nDC Dendritic cell  \nDEG Differentially expressed gene  \nFFPE Formalin-fixed, paraffin-embedded  \nGO Gene ontology  \nHLA Human leukocyte antigen  \nHNSCC Head and neck squamous cell carcinoma HTL Helper T lymphocyte  \nICI Immune checkpoint inhibitor  \nIFN-γ Interferon-gamma  \nIHC  \nKEGG  \nL-cells  \nMHC  \nORF  \nPADRE  \nPBMC  \nPEG10  \nRF1 RF1/2 RNA-seq SCC  \nsg-PEG10  \nsgRNA  \nsg-scr  \nsi-NC  \nsi-PEG10  \nsiRNA  \nImmunohistochemical  \nKyoto Encyclopedia of Genes and Genomes Mouse fibroblast cell lines  \nMajor histocompatibility complex Open reading frame  \nPan DR epitope  \nPeripheral blood mononuclear cell Paternally expressed gene 10  \nPEG10-ORF1 protein  \nPEG10-ORF1 and ORF2 fusion protein RNA ","cbCaiigBWJGb2W4f","https://ap.wps.com/l/cbCaiigBWJGb2W4f","pdf",8076435,15,"English","# Abstract\n# Introduction\n## Immune checkpoint inhibitors in HNSCC\n## Peptide-based vaccination and helper epitope peptides\n## Cancer-testis and cancer-placental antigens as targets","[{\"question\":\"What is PEG10 and why is it considered a potential cancer immunotherapy target?\",\"answer\":\"PEG10 is primarily expressed in the placenta, with extremely low or absent expression in normal tissues, but it is up-regulated in various cancers, suggesting it can serve as an immunotherapy target.\"},{\"question\":\"How does PEG10 expression relate to patient outcomes in head and neck squamous cell carcinoma?\",\"answer\":\"High PEG10 expression in HNSCC is associated with poor patient survival.\"},{\"question\":\"What did the study identify as a PEG10-derived helper T-cell epitope and how does it work?\",\"answer\":\"The study identified a PEG10-derived peptide epitope (PEG10216-232) that induces antigen-specific and promiscuous HLA-DR-restricted helper T lymphocyte responses. PEG10-specific HTLs can directly kill PEG10-positive HNSCC cells in an HLA-DR-restricted manner.\"}]","Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinoma | PDF",1790192432,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a79f60ce5c1277439eae397950c4a88.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a31776ad980df6029958231c7808079.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/441de08bc5d262d284069307e961287d.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b851db2c590693ad9246baf3f152ba11.webp",980,1301]